--- schema_version: "secwatch.filing_event.v1" accession: "0001104659-23-080024" form_type: "8-K" ticker: "NVAX" cik: "0001000694" company_name: "NOVAVAX INC" filed_at: "2023-07-11T23:59:59+00:00" generated_at: "2026-06-13T09:44:56.377834+00:00" event_type: "other_material" sentiment: "neutral" materiality_score: 0.5 calibrated_materiality_score: 0.5 confidence: "high" source: SEC EDGAR --- # Novavax stockholders approve 6.17M share increase under Amended 2015 Stock Plan ## Summary - Proposal 5 approved: Amended 2015 Stock Plan with 15.1M for, 3.8M against; adds 6,170,000 authorized shares. - Proposal 4 failed: officer exculpation charter amendment received 16.7M for, 2.1M against, but not approved. - Directors elected: John C. Jacobs (18.1M for), Gregg H. Alton (11.3M for), Richard J. Rodgers (13.1M for). - Advisory say-on-pay approved (15.7M for); frequency set at one year (17.8M for one-year option). - Ratification of Ernst & Young as auditor passed with 41.4M for, 2.0M against. ## SEC filing metadata - accession: 0001104659-23-080024 - form_type: 8-K - ticker: NVAX - cik: 0001000694 - company_name: NOVAVAX INC - filed_at: 2023-07-11T23:59:59+00:00 - event_type: other_material - sentiment: neutral - materiality_score: 0.5 - calibrated_materiality_score: 0.5 - confidence: high - sec_items: 5.02, 5.07, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1000694/000110465923080024/0001104659-23-080024-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000694/000110465923080024/tm2321057d1_8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001104659-23-080024 - JSON: https://secwatch.observer/filing/0001104659-23-080024.json - Plain text: https://secwatch.observer/filing/0001104659-23-080024.txt ## Key facts - Shareholder Votes NOVAVAX INC shareholders approved Advisory vote on the frequency of future named executive officer compensation votes at the 2023-07-11 meeting. - Proposal: say on pay frequency - Outcome: passed - Meeting: 2023-07-11 source text: Proposal 3 : Stockholders approved, on an advisory basis, the frequency of future named executive officer compensation votes: One Year Two Years Three Years Abstaining Broker Non-Votes 17,803,121 342,423 846,988 271,533 24,476,819 evidence_url: https://www.sec.gov/Archives/edgar/data/1000694/000110465923080024/0001104659-23-080024-index.htm - Shareholder Votes NOVAVAX INC shareholders approved Amendment and restatement of the Novavax Inc. Amended and Restated 2015 Stock Incentive Plan to increase the number of shares available for issuance by 6,170,000 at the 2023-07-11 meeting. - Proposal: equity plan - Outcome: passed - Meeting: 2023-07-11 source text: Proposal 5 : Stockholders approved the amendment and restatement of the Novavax Inc. Amended and Restated 2015 Stock Incentive Plan to increase the number of shares of Common Stock available for issuance thereunder by 6,170,000 shares: For Against Abstaining Broker Non-Votes 15,131,768 3,824,183 308,114 24,476,819 evidence_url: https://www.sec.gov/Archives/edgar/data/1000694/000110465923080024/0001104659-23-080024-index.htm - Shareholder Votes NOVAVAX INC shareholders approved Election of Class I nominees for director at the 2023-07-11 meeting. - Proposal: director election - Outcome: passed - Meeting: 2023-07-11 source text: Proposal 1 : Stockholders elected the following Class I nominees for director, each to serve a three-year term expiring at the 2026 Annual Meeting of Stockholders: Name For Against Abstain Broker Non-Votes John C. Jacobs 18,096,901 881,806 285,358 24,476,819 Gregg H. Alton, J.D. 11,319,429 7,498,303 446,333 24,476,819 Richard J. Rodgers 13,138,940 5,662,283 462,842 24,476,819 evidence_url: https://www.sec.gov/Archives/edgar/data/1000694/000110465923080024/0001104659-23-080024-index.htm - Shareholder Votes NOVAVAX INC shareholders rejected Amendment to the Second Amended and Restated Certificate of Incorporation to reflect Delaware law provisions allowing officer exculpation at the 2023-07-11 meeting. - Proposal: charter amendment - Outcome: failed - Meeting: 2023-07-11 source text: Proposal 4 : Stockholders did not approve the amendment to the Second Amended and Restated Certificate of Incorporation of Novavax, Inc. to reflect Delaware law provisions allowing officer exculpation: For Against Abstaining Broker Non-Votes 16,746,786 2,058,948 458,331 24,476,819 evidence_url: https://www.sec.gov/Archives/edgar/data/1000694/000110465923080024/0001104659-23-080024-index.htm - Shareholder Votes NOVAVAX INC shareholders approved Advisory vote on the compensation paid to the Company’s named executive officers in 2022 at the 2023-07-11 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2023-07-11 source text: Proposal 2 : Stockholders approved, on an advisory basis, the compensation paid to the Company’s named executive officers in 2022: For Against Abstaining Broker Non-Votes 15,695,578 3,030,052 538,435 24,476,819 evidence_url: https://www.sec.gov/Archives/edgar/data/1000694/000110465923080024/0001104659-23-080024-index.htm - Shareholder Votes NOVAVAX INC shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-07-11 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2023-07-11 source text: Proposal 6 : Stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023: For Against Abstaining Broker Non-Votes 41,350,254 2,005,826 384,804 — evidence_url: https://www.sec.gov/Archives/edgar/data/1000694/000110465923080024/0001104659-23-080024-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.